The global endoscopic retrograde cholangiopancreatography market was valued at USD 1.5 billion in 2021 and it is anticipated to grow up to USD 2.9 billion by 2031, at a CAGR of 6.5% during the forecast period.
In order to diagnose and treat disorders of the bile and pancreatic ducts, endoscopic retrograde cholangiopancreatography (ERCP) combines endoscopy with x-ray technology. The use of precut sphincterotomy during endoscopic retrograde cholangiopancreatography (ERCP) may increase the likelihood that a cannulation will be successful, but it is associated with an increased risk of post-ERCP pancreatitis. For patients with difficult biliary access, applying precut sphincterotomy involving sphincterotomes sooner rather than later may reduce this risk.
Major Players in the global endoscopic cholangiopancreatography Market
The key players studied in the market are Olympus Corporation (Japan), CONMED Corporation (US), Fujifilm Holdings Corporation (Japan), HOYA Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Ambu A/S (Denmark), Boston Scientific Corporation (US), Johnson & Johnson (US), Medtronic, PLC (Ireland), Cook Medical (US), B. Braun Melsungen AG (Germany), Hobbs Medical, Inc. (US), STERIS PLC (US), Merit Medical Systems, Inc. (US), TeleMed Systems, Inc. (US),
To Remain ‘Ahead’ Of Your Competitors, Request for A Sample – https://www.globalinsightservices.com/request-sample/GIS10278
Global Endoscopic Cholangiopancreatography Market Segmental Overview
The report analyses global endoscopic cholangiopancreatography market based on product, procedure, end users, and region.
Global Endoscopic Cholangiopancreatography Market by Product
Based on product, it is segmented into endoscopes, endotherapy devices, visualization systems, energy devices, and others. The endotherapy devices segment is likely to dominate the market during the forecast period. The key factors such as the growth of minimally invasive surgeries coupled with the increasing prevalence of gastrointestinal conditions are boosting the growth of the market.
Global Endoscopic Cholangiopancreatography Market by Procedure
Based on procedure, it is segmented into biliary sphincterotomy, biliary stenting, biliary dilatation, pancreatic sphincterotomy, pancreatic duct stenting, and pancreatic duct dilatation. The biliary sphincterotomy segment is likely to account for the majority of the market share during the forecast period. The key factors such as increasing pancreatic duct and bile duct stones coupled with the increase in the geriatric population are boosting the growth of the market.
For In-Depth Competitive Analysis, Purchase this Report – https://www.globalinsightservices.com/inquiry-before-buying/GIS10278
Market Trends and Drivers
The incidence of cancer is rising globally today. Cancer was the second-leading cause of death worldwide in 2018, accounting for 9.6 million fatalities, according to the WHO. The American Cancer Society predicts that in 2022, there will be roughly 41,260 new instances of liver cancer and intrahepatic bile duct cancer detected in the US. Since 1980, the incidence of liver cancer has more than tripled, while the fatality rate has more than doubled. About 60,430 new cases of the pancreatic disease were identified in the US in 2021.
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm
headquartered in Delaware, US. We are committed to providing our clients
with highest quality data, analysis, and tools to meet all their market research
needs. With GIS, you can be assured of the quality of the deliverables, robust
and transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700